查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1790309

美國mRNA 合成原料市場規模、佔有率和趨勢分析報告：按類型、應用、最終用途和細分市場預測，2025 年至 2033 年

U.S. mRNA Synthesis Raw Materials Market Size, Share & Trends Analysis Report By Type (Capping Agents, Nucleotides, Plasmid DNA, Enzymes), By Application (Vaccine Production, Therapeutics Production), By End Use, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 90 Pages | 商品交期: 2-10個工作天內

價格

美國mRNA合成原料市場摘要

美國mRNA 合成原料市場規模預計在 2024 年為 5.41 億美元，預計到 2033 年將達到 9.322 億美元，2025 年至 2033 年的複合年成長率為 6.57%。推動這一成長的因素包括學術界和工業界對 mRNA 技術的興趣日益濃厚、mRNA 研究資金增加以及人們對基於 mRNA 的疫苗益處的認知不斷提高。

此外，預計 RNA 技術日益成長的治療應用將在預測期內推動對 mRNA 合成原料的大量需求。

目錄

第1章調查方法與範圍

第2章執行摘要

第3章市場變數、趨勢和範圍

  • 市場體系展望
    • 母市場展望
    • 相關/輔助市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
    • 市場問題分析
  • 產業分析工具
    • 波特五力分析
    • PESTEL分析

第4章 類型業務分析

  • 類型細分儀表板
  • 美國mRNA合成原料市場波動分析
  • 美國mRNA 合成原料市場規模及趨勢分析（2021-2033）
  • 封端劑
    • CleanCap 試劑
    • ARCA（防反接電容模擬）
    • 其他
  • 核苷酸
    • 修飾核酸
    • 天然核酸
  • 質體DNA
  • 酵素
    • 聚合酵素
    • RNase抑制劑
    • DNase
    • 其他
  • 其他

第5章：應用業務分析

  • 應用程式細分儀表板
  • 美國mRNA合成原料市場使用趨勢分析
  • 美國mRNA 合成原料市場規模及趨勢分析（依應用，2021-2033）
  • 治療藥物製造
  • 疫苗生產
  • 其他用途

第6章 最終用途業務分析

  • 最終用途細分儀表板
  • 美國mRNA合成原料市場最終用途差異分析
  • 美國mRNA 合成原料市場規模及趨勢分析（依最終用途，2021-2033 年）
  • 生物製藥和製藥公司
  • CRO 和 CMO
  • 學術研究機構

第7章 競爭態勢

  • 公司分類
  • 戰略地圖
  • 2024年企業市場分析
  • 公司簡介/上市公司
    • F. Hoffmann-La Roche Ltd.
    • Jena Bioscience GmbH
    • Merck KGaA
    • Yeasen Biotechnology（Shanghai）Co., Ltd
    • BOC Sciences
    • Thermo Fisher Scientific, Inc.
    • Maravai LifeSciences
    • New England Biolabs
    • Creative Biogene
    • HONGENE
    • Evonik Industries AG
    • GENEVANT SCIENCES CORPORATION
Product Code: GVR-4-68040-283-7

U.S. mRNA Synthesis Raw Materials Market Summary

The U.S. mRNA synthesis raw materials market size was estimated at USD 541.0 million in 2024 and is projected to reach USD 932.2 million by 2033, growing at a CAGR of 6.57% from 2025 to 2033. This growth is attributed to the growing academic & industrial interest in mRNA technology, increasing funding for mRNA research, and rising awareness of the advantages of mRNA-based vaccines.

Moreover, the increasing therapeutic applications of RNA technology are anticipated to provide significant demand for the mRNA synthesis raw materials over the forecast period.

U.S. mRNA Synthesis Raw Materials Market Report Segmentation

This report forecasts revenue growth in the U.S. and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the U.S. mRNA synthesis raw materials market report based on type, application, and end use:

  • Type Outlook (Revenue, USD Million, 2021 - 2033)
  • Capping Agents
  • CleanCap Reagents
  • ARCA (Anti-Reverse Cap Analog)
  • Others
  • Nucleotides
  • Modified Nucleic Acids
    • N1-methylpseudouridine-triphosphate
    • 5-Methylcytidine triphosphate (5mCTP)
    • Others
  • Natural Nucleic Acids
    • Adenine
    • Guanine
    • Cytosine
    • Uracil
  • Plasmid DNA
  • Enzymes
  • Polymerase
  • RNase Inhibitor
  • DNase
  • Others
  • Others
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Vaccine Production
  • Therapeutics Production
  • Others
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Biopharmaceutical & Pharmaceutical Companies
  • CROs & CMOs
  • Academic & Research Institutes

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
    • 1.1.1. Type Segment
    • 1.1.2. Application Segment
    • 1.1.3. End Use Segment
  • 1.2. Estimates and Forecast Timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased Database
    • 1.4.2. GVR's Internal Database
    • 1.4.3. Primary Research
  • 1.5. Information or Data Analysis:
    • 1.5.1. Data Analysis Models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity Flow Analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Abbreviations
  • 1.10. Objective

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Growing academic & industrial interest in mRNA technology
      • 3.2.1.2. Advantages of mRNA vaccines
      • 3.2.1.3. Increasing funding for mRNA research
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Nonexistence of effective government regulations for mRNA-based product approvals
      • 3.2.2.2. High cost of mRNA synthesis raw materials
    • 3.2.3. Market Challenge Analysis
      • 3.2.3.1. Lack of long-lasting and affordable manufacturing processes
  • 3.3. Industry Analysis Tools
    • 3.3.1. Porter's Five Forces Analysis
    • 3.3.2. PESTEL Analysis

Chapter 4. Type Business Analysis

  • 4.1. Type Segment Dashboard
  • 4.2. U.S. mRNA Synthesis Raw Materials Market Type Movement Analysis
  • 4.3. U.S. mRNA Synthesis Raw Materials Market Size & Trend Analysis, by Type, 2021 to 2033 (USD Million)
  • 4.4. Capping Agents
    • 4.4.1. Capping agents market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.4.2. CleanCap Reagents
      • 4.4.2.1. CleanCap reagents market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.4.3. ARCA (Anti-Reverse Cap Analog)
      • 4.4.3.1. ARCA (anti-reverse cap analog) market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.4.4. Others
      • 4.4.4.1. Others market estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.5. Nucleotides
    • 4.5.1. Nucleotides market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.5.2. Modified Nucleic Acids
      • 4.5.2.1. Modified nucleic acids market estimates and forecasts, 2021 - 2033 (USD Million)
      • 4.5.2.2. N1-methylpseudouridine-triphosphate
        • 4.5.2.2.1. N1-methylpseudouridine-triphosphate market estimates and forecasts, 2021 - 2033 (USD Million)
      • 4.5.2.3. 5-Methylcytidine triphosphate (5mCTP)
        • 4.5.2.3.1. 5-Methylcytidine triphosphate (5mCTP) market estimates and forecasts, 2021 - 2033 (USD Million)
      • 4.5.2.4. Others
        • 4.5.2.4.1. Others market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.5.3. Natural Nucleic Acids
      • 4.5.3.1. Natural nucleic acids market estimates and forecasts, 2021 - 2033 (USD Million)
      • 4.5.3.2. Adenine
        • 4.5.3.2.1. Adenine market estimates and forecasts, 2021 - 2033 (USD Million)
      • 4.5.3.3. Guanine
        • 4.5.3.3.1. Guanine market estimates and forecasts, 2021 - 2033 (USD Million)
      • 4.5.3.4. Cytosine
        • 4.5.3.4.1. Cytosine market estimates and forecasts, 2021 - 2033 (USD Million)
      • 4.5.3.5. Uracil
        • 4.5.3.5.1. Uracil market estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.6. Plasmid DNA
    • 4.6.1. Plasmid DNA market estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.7. Enzymes
    • 4.7.1. Enzymes market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.7.2. Polymerase
      • 4.7.2.1. Polymerase market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.7.3. RNase Inhibitor
      • 4.7.3.1. RNase inhibitor market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.7.4. DNase
      • 4.7.4.1. DNase market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.7.5. Others
      • 4.7.5.1. Others market estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.8. Others
    • 4.8.1. Others market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 5. Application Business Analysis

  • 5.1. Application Segment Dashboard
  • 5.2. U.S. mRNA Synthesis Raw Materials Market Application Movement Analysis
  • 5.3. U.S. mRNA Synthesis Raw Materials Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
  • 5.4. Therapeutics Production
    • 5.4.1. Therapeutics production market estimates and forecasts, 2021 - 2033 (USD Million)
  • 5.5. Vaccine Production
    • 5.5.1. Vaccine production market estimates and forecasts, 2021 - 2033 (USD Million)
  • 5.6. Other Application
    • 5.6.1. Other application market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 6. End Use Business Analysis

  • 6.1. End Use Segment Dashboard
  • 6.2. U.S. mRNA Synthesis Raw Materials Market End Use Movement Analysis
  • 6.3. U.S. mRNA Synthesis Raw Materials Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
  • 6.4. Biopharmaceutical & Pharmaceutical Companies
    • 6.4.1. Biopharmaceutical & pharmaceutical companies market estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.5. CROs & CMOs
    • 6.5.1. CROs & CMOs market estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.6. Academic & Research Institutes
    • 6.6.1. Academic & research institutes market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Company Categorization
  • 7.2. Strategy Mapping
  • 7.3. Company Market Position Analysis, 2024
  • 7.4. Company Profiles/Listing
    • 7.4.1. F. Hoffmann-La Roche Ltd.
      • 7.4.1.1. Overview
      • 7.4.1.2. Financial Performance
      • 7.4.1.3. Product Benchmarking
      • 7.4.1.4. Strategic Initiatives
    • 7.4.2. Jena Bioscience GmbH
      • 7.4.2.1. Overview
      • 7.4.2.2. Product Benchmarking
      • 7.4.2.3. Strategic Initiatives
    • 7.4.3. Merck KGaA
      • 7.4.3.1. Overview
      • 7.4.3.2. Financial Performance
      • 7.4.3.3. Product Benchmarking
      • 7.4.3.4. Strategic Initiatives
    • 7.4.4. Yeasen Biotechnology (Shanghai) Co., Ltd
      • 7.4.4.1. Overview
      • 7.4.4.2. Product Benchmarking
      • 7.4.4.3. Strategic Initiatives
    • 7.4.5. BOC Sciences
      • 7.4.5.1. Overview
      • 7.4.5.2. Product Benchmarking
      • 7.4.5.3. Strategic Initiatives
    • 7.4.6. Thermo Fisher Scientific, Inc.
      • 7.4.6.1. Overview
      • 7.4.6.2. Financial Performance
      • 7.4.6.3. Product Benchmarking
      • 7.4.6.4. Strategic Initiatives
    • 7.4.7. Maravai LifeSciences
      • 7.4.7.1. Overview
      • 7.4.7.2. Financial Performance
      • 7.4.7.3. Product Benchmarking
      • 7.4.7.4. Strategic Initiatives
    • 7.4.8. New England Biolabs
      • 7.4.8.1. Overview
      • 7.4.8.2. Product Benchmarking
      • 7.4.8.3. Strategic Initiatives
    • 7.4.9. Creative Biogene
      • 7.4.9.1. Overview
      • 7.4.9.2. Product Benchmarking
      • 7.4.9.3. Strategic Initiatives
    • 7.4.10. HONGENE
      • 7.4.10.1. Overview
      • 7.4.10.2. Product Benchmarking
      • 7.4.10.3. Strategic Initiatives
    • 7.4.11. Evonik Industries AG
      • 7.4.11.1. Overview
      • 7.4.11.2. Financial Performance
      • 7.4.11.3. Product Benchmarking
      • 7.4.11.4. Strategic Initiatives
    • 7.4.12. GENEVANT SCIENCES CORPORATION
      • 7.4.12.1. Overview
      • 7.4.12.2. Product Benchmarking
      • 7.4.12.3. Strategic Initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 U.S. mRNA synthesis raw materials market, by type, 2021 - 2033 (USD Million)
  • Table 4 U.S. mRNA synthesis raw materials market, by application, 2021 - 2033 (USD Million)
  • Table 5 U.S. mRNA synthesis raw materials market, by end use, 2021 - 2033 (USD Million)
  • Table 6 Key companies undergoing expansions.
  • Table 7 Key companies undergoing acquisitions.
  • Table 8 Key companies undergoing collaborations.
  • Table 9 Key companies launching new products/services.
  • Table 10 Key companies undertaking other strategies.

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Market formulation & validation
  • Fig. 6 U.S. mRNA synthesis raw materials market: market outlook
  • Fig. 7 U.S. mRNA synthesis raw materials competitive insights
  • Fig. 8 Parent market outlook
  • Fig. 9 U.S. mRNA synthesis raw materials market driver impact
  • Fig. 10 U.S. mRNA synthesis raw materials market restraint impact: Type & services movement analysis
  • Fig. 11 U.S. mRNA synthesis raw materials market: Type outlook and key takeaways
  • Fig. 12 Capping agents market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 13 CleanCap reagents market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 14 ARCA (anti-reverse cap analog) market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 15 Others market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 16 Nucleotides market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 17 Modified nucleic acids market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 18 N1-methylpseudouridine-triphosphate market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 19 5-Methylcytidine triphosphate (5mCTP) market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 20 Others market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 21 Natural nucleic acids market estimates and forecasts,2021 - 2033 (USD Million)
  • Fig. 22 Adenine market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 23 Guanine market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 24 Cytosine market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 25 Uracil market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 26 Plasmid DNA market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 27 Enzymes market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 28 Polymerase market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 29 RNase inhibitor market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 30 DNase materials market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 31 Others market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 32 Others market estimates and forecasts,2021 - 2033 (USD Million)
  • Fig. 33 U.S. mRNA synthesis raw materials market: Application movement analysis
  • Fig. 34 U.S. mRNA synthesis raw materials market: Application outlook and key takeaways
  • Fig. 35 Vaccine production market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 36 Therapeutics production market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 37 Other application market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 38 U.S. mRNA synthesis raw materials market: End Use movement analysis
  • Fig. 39 U.S. mRNA synthesis raw materials market: End Use outlook and key takeaways
  • Fig. 40 Academic & research institutes market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 41 Biopharmaceutical & pharmaceutical companies market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 42 CROs CMOs market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 43 Market share of key market players - U.S. mRNA synthesis raw materials market